3 Firms Seek $4M For CytoDyn Stock Award Suit Settlement
Three firms told the Delaware Chancery Court on Friday they are seeking $4.1 million in fees in connection with a proposed stockholder suit settlement that will require five directors of life...To view the full article, register now.
Already a subscriber? Click here to view full article